Curriculum Vitae

Scopus ID 6602197182

Dr. Pozzobon graduated in Pharmaceutical Chemistry at the University of Padua in 2000 and then joined the Dept. of Pharmaceutical Chemistry with an 18 months fellowship on an EU project on polymer synthesis. Dr. Pozzobon spent 3 years (2002-2004) at the University of Oxford as Research Assistant in the Oncology Group (Nuffield Dept. of Clinical Sciences, UK) under the supervision of Prof David Y. Mason. Since 2004, she joined the lab of Stem Cells and Regenerative Medicine, working with Dr. Paolo De Coppi which she has been coordinating since 2010. During this time, Dr. Pozzobon enrolled in the PhD program in Tissue Engineering and Regenerative Medicine at the University of Padua which was completed in 2008. Her research activity is focused on the study of the tissue biology and the application in regenerative medicine (cell therapy and tissue engineering), specifically in the pediatric field with focus on muscle related problems. Dr. Pozzobon is actively involved in national and international projects, and is MC member of the COST European project SPRINT on perinatal stem cells (2019-2021). Her expertise combines the training in oncologic field and the research on regenerative medicine. Since 2004, her studies on stem cells from amniotic fluid stem cells (fetal stem cells) and from skeletal muscle (adult stem cells) used with regenerative medicine/tissue engineering approaches have been applied on murine models of muscle disease or defects. In 2016, Dr. Pozzobon obtained the senior research fellowship number GRIC15AIPF of the University of Padua and in 2019 was awarded the IRP-Synergy grant 2019 to investigate the interaction of extracellular vesicles and extracellular matrix.

E-mail: m.pozzobon@irpcds.org


Latest pubblications: Click here

Related Laboratories

Stem cells and regenerative medicine

The group has been focused in the past 12 years on developing strategies for tissue regeneration for the paediatric patients.

Stem cells and regenerative medicine

The group has been focused in the past 12 years on developing strategies for tissue regeneration for the paediatric patients.